Thomas W. North

2.2k total citations
57 papers, 1.8k citations indexed

About

Thomas W. North is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Thomas W. North has authored 57 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Infectious Diseases, 42 papers in Virology and 20 papers in Molecular Biology. Recurrent topics in Thomas W. North's work include HIV Research and Treatment (42 papers), HIV/AIDS drug development and treatment (42 papers) and HIV/AIDS Research and Interventions (15 papers). Thomas W. North is often cited by papers focused on HIV Research and Treatment (42 papers), HIV/AIDS drug development and treatment (42 papers) and HIV/AIDS Research and Interventions (15 papers). Thomas W. North collaborates with scholars based in United States, Poland and Belgium. Thomas W. North's co-authors include Niels C. Pedersen, K M Remington, Raymond F. Schinazi, Joanne Higgins, Seymour S. Cohen, Bradley D. Preston, Paul A. Luciw, C K Mathews, Richard Cronn and George J. Klarmann and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Thomas W. North

57 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas W. North United States 25 1.1k 895 509 504 279 57 1.8k
Nick Vandegraaff United States 21 1.3k 1.2× 893 1.0× 390 0.8× 864 1.7× 198 0.7× 25 1.8k
B. Öberg Sweden 23 488 0.4× 624 0.7× 644 1.3× 495 1.0× 224 0.8× 67 1.6k
Olivier Delelis France 27 1.6k 1.5× 1.6k 1.7× 339 0.7× 1.1k 2.2× 212 0.8× 66 2.2k
Joséphine Sire France 25 1.1k 1.0× 824 0.9× 346 0.7× 738 1.5× 121 0.4× 49 1.8k
A.‐M. Aubertin France 19 659 0.6× 407 0.5× 386 0.8× 389 0.8× 84 0.3× 56 1.2k
Jason W. Rausch United States 28 940 0.8× 848 0.9× 302 0.6× 1.0k 2.1× 132 0.5× 55 1.8k
Atsushi Koito Japan 24 1.1k 1.0× 574 0.6× 294 0.6× 556 1.1× 95 0.3× 43 1.8k
Tran C. Chanh United States 23 770 0.7× 348 0.4× 343 0.7× 585 1.2× 154 0.6× 53 1.9k
Zene Matsuda Japan 24 1.1k 1.0× 1.1k 1.3× 458 0.9× 689 1.4× 321 1.2× 47 2.3k
Thierry Huet France 13 713 0.6× 482 0.5× 296 0.6× 423 0.8× 120 0.4× 18 1.2k

Countries citing papers authored by Thomas W. North

Since Specialization
Citations

This map shows the geographic impact of Thomas W. North's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas W. North with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas W. North more than expected).

Fields of papers citing papers by Thomas W. North

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas W. North. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas W. North. The network helps show where Thomas W. North may publish in the future.

Co-authorship network of co-authors of Thomas W. North

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas W. North. A scholar is included among the top collaborators of Thomas W. North based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas W. North. Thomas W. North is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wadford, Debra A., Robert C. Kauffman, Jesse D. Deere, et al.. (2014). Variation of Human Immunodeficiency Virus Type-1 Reverse Transcriptase within the Simian Immunodeficiency Virus Genome of RT-SHIV. PLoS ONE. 9(1). e86997–e86997. 1 indexed citations
2.
Deere, Jesse D., Robert C. Kauffman, Elda Cannavò, et al.. (2014). Analysis of Multiply Spliced Transcripts in Lymphoid Tissue Reservoirs of Rhesus Macaques Infected with RT-SHIV during HAART. PLoS ONE. 9(2). e87914–e87914. 15 indexed citations
3.
Deere, Jesse D., Joanne Higgins, Elda Cannavò, et al.. (2010). Viral Decay Kinetics in the Highly Active Antiretroviral Therapy-Treated Rhesus Macaque Model of AIDS. PLoS ONE. 5(7). e11640–e11640. 12 indexed citations
4.
Deere, Jesse D., Raymond F. Schinazi, & Thomas W. North. (2010). Simian immunodeficiency virus macaque models of HIV latency. Current Opinion in HIV and AIDS. 6(1). 57–61. 22 indexed citations
5.
6.
Duong, Yen T., D. Christopher Meadows, Indresh K. Srivastava, Jacquelyn Gervay‐Hague, & Thomas W. North. (2007). Direct Inactivation of Human Immunodeficiency Virus Type 1 by a Novel Small-Molecule Entry Inhibitor, DCM205. Antimicrobial Agents and Chemotherapy. 51(5). 1780–1786. 5 indexed citations
7.
Joshi, Pheroze, Thomas W. North, & Vinayaka R. Prasad. (2005). Aptamers directed to HIV-1 reverse transcriptase display greater efficacy over small hairpin RNAs targeted to viral RNA in blocking HIV-1 replication. Molecular Therapy. 11(5). 677–686. 47 indexed citations
8.
Klarmann, George J., Xin Chen, Thomas W. North, & Bradley D. Preston. (2003). Incorporation of Uracil into Minus Strand DNA Affects the Specificity of Plus Strand Synthesis Initiation during Lentiviral Reverse Transcription. Journal of Biological Chemistry. 278(10). 7902–7909. 63 indexed citations
9.
Pedersen, Niels C., Thomas W. North, Richard Rigg, et al.. (2003). 16α-Bromo-epiandrosterone therapy modulates experimental feline immunodeficiency virus viremia: initial enhancement leading to long-term suppression. Veterinary Immunology and Immunopathology. 94(3-4). 133–148. 18 indexed citations
10.
11.
Leutenegger, Christian M., Joanne Higgins, Alice F. Tarantal, et al.. (2001). Real-Time TaqMan PCR as a Specific and More Sensitive Alternative to the Branched-Chain DNA Assay for Quantitation of Simian Immunodeficiency Virus RNA. AIDS Research and Human Retroviruses. 17(3). 243–251. 105 indexed citations
12.
Klarmann, George J., Robert A. Smith, Raymond F. Schinazi, Thomas W. North, & Bradley D. Preston. (2000). Site-specific Incorporation of Nucleoside Analogs by HIV-1 Reverse Transcriptase and the Template Grip Mutant P157S. Journal of Biological Chemistry. 275(1). 359–366. 27 indexed citations
13.
14.
LaCasse, Rachel, K M Remington, & Thomas W. North. (1996). The Mutation Frequency of Feline Immunodeficiency Virus Enhanced by 3'-Azido-3'-deoxythymidine. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 12(1). 26–32. 9 indexed citations
15.
North, Thomas W. & Rachel LaCasse. (1995). Testing anti–HIV drugs in the FIV model. Nature Medicine. 1(5). 410–411. 20 indexed citations
16.
Kimberlin, David W., et al.. (1995). Models of antiviral resistance. Antiviral Research. 26(4). 415–422. 2 indexed citations
17.
Barlough, Jeffrey E., Thomas W. North, K M Remington, et al.. (1993). Feline immunodeficiency virus infection of cats as a model to test the effect of certain in vitro selection pressures on the infectivity and virulence of resultant lentivirus variants. Antiviral Research. 22(4). 259–272. 18 indexed citations
18.
Cronn, Richard, K M Remington, Bradley D. Preston, & Thomas W. North. (1992). Inhibition of reverse transcriptase from feline immunodeficiency virus by analogs of 2′-deoxyadenosine-5′-triphosphate. Biochemical Pharmacology. 44(7). 1375–1381. 20 indexed citations
19.
North, Thomas W., et al.. (1990). Characterization of reverse transcriptase from feline immunodeficiency virus.. Journal of Biological Chemistry. 265(9). 5121–5128. 58 indexed citations
20.
North, Thomas W., et al.. (1983). Effects of chirality in 9-(2-hydroxy-3-nonyl)adenine upon deoxyribonucleic acid synthesis in herpes simplex virus-infected cells. Biochemical Pharmacology. 32(23). 3541–3546. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nick Vandegraaff Breakdown of academic impact, for papers by B. Öberg Breakdown of academic impact, for papers by Olivier Delelis Breakdown of academic impact, for papers by Joséphine Sire Breakdown of academic impact, for papers by A.‐M. Aubertin Breakdown of academic impact, for papers by Jason W. Rausch Breakdown of academic impact, for papers by Atsushi Koito Breakdown of academic impact, for papers by Tran C. Chanh Breakdown of academic impact, for papers by Zene Matsuda Breakdown of academic impact, for papers by Thierry Huet
Rankless by CCL
2026